In a pooled analysis of two other studies conducted in unvaccinated otherwise healthy adults, oseltamivir 75 mg once daily given for 6 weeks significantly reduced the incidence of clinical influenza illness from 25/ 519 (4.8%) in the placebo
Profülaktika gripiepideemia ajal elanikkonnas: kahes teises uuringus osalesid vaktsineerimata, muidu terved täiskasvanud.